Abstract
Background The emergence of Coronavirus disease 2019 (COVID-19) an infectious disease caused by the newly discovered severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) has caused a lot of harm to humanity. Healthcare workers who are the leading the charge in the fight against the virus can experience mental health challenges with anxiety being an important illness. Anxiety can become morbid quickly and ultimately affect function, hence the need to study its prevalence among HCWs, since they are a high-risk population. Studies across various regions worldwide reported elevated levels of anxiety amongst HCWs during the SARS, Ebola, and H1N1 pandemics. Nevertheless, Generalized Anxiety Disorder (GAD), an easily measured and ubiquitous member of the family of anxiety disorders has hardly been researched. However, new studies in Togo, China, India and Mexico have reported elevated levels of GAD in HCWs during the COVID-19 pandemic. Given the complexities surrounding mental health care in Ghana, and Africa as a whole it would be expedient to uncover the prevalence of GAD among HCWs during the pandemic. Hence, a study at Family Health Hospital will provide information about the prevalence of COVID-19 related GAD among Health care workers representative of Ghana.
Aim The aim of this study was to establish the prevalence of COVID-19 related GAD amongst healthcare workers, in a tertiary hospital in Accra.
Methods A descriptive cross-sectional study design using a self-administered questionnaire was employed. Nine-two (92) HCWs in the study area were sampled. A consecutive sampling technique was used to select the respondents for the study. The study was analyzed using SPSS version 25. The results were presented in summary tables and analyzed using frequencies and percentages. Chi square test performed on categorical data to test association between selected variables and their outcome with COVID-19 related GAD.
Results The GAD level among nurses was 55.4%, and for doctors it was 30.4%. The GAD level among medical laboratory technicians and pharmacists were 7.6% and 6.5% respectively. Furthermore, being age 50-69 years was a significant risk factor for developing GAD during the COVID-19 pandemic in Ghana. Female HCWs were more likely to experience GAD. However, only 13.1% of the HCWs were considered to have Corona phobia. Perception of workplace as being high risk was positively correlated with mild to moderate forms of anxiety. However, perception of organizational support as being guaranteed in case one succumbed to the virus and confidence in PPE availability was not reported to be strong protective factors against GAD among HCWs.
Conclusion COVID-19 related GAD is a challenge amongst HCWs especially nurses in FHH. The management of the FHH should set up certain services such as psychological help lines, peer support programs as well as run a sensitization campaign to cater for the wellbeing of doctors as well as encourage mental health seeking behavior.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Community Health Department Review Committee, University of Ghana Medical School gave ethics approval
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present work are contained in the manuscript
